Pulmonary Hypertension

A hypochromic red cells concentration of more than 2% is an independent predictor of mortality in patients with systemic sclerosis, according to data published in Arthritis Research & Therapy.

Inhaled treprostinil is used to treat pulmonary hypertension with interstitial lung disease, and a study recently found that higher doses led to better clinical outcomes than a lower dose or placebo.

NEW ORLEANS — Sotatercept, a novel activin signaling inhibitor, reduced risk for death and clinical worsening by 84% in patients with pulmonary arterial hypertension compared with placebo, according to results of the STELLAR trial.

A patient in her early 30s with a history of severe pulmonary hypertension came into my office and expressed that she would like to start a family.

Chest sensors that measured heart rate and accelerometry enabled patients with pulmonary artery hypertension to undergo 6-minute walk tests remotely with similar data as those collected in clinic, according to study results in CHEST.

NASHVILLE, Tenn. — Patients admitted with background secondary pulmonary hypertension may have an increased risk for acute kidney injury and adverse outcomes, according to a presenter at the CHEST Annual Meeting.

Decreasing pulmonary hyperinflation using bronchoscopic lung volume reduction improved cardiac preload, contractility and output in a cohort of patients with emphysema, according to study findings.

Patients with pulmonary hypertension associated with interstitial lung disease had better outcomes with a higher dose of inhaled treprostinil, as compared with a lower dose or placebo, according to a study.

Treatment with sildenafil or tadalafil was not associated with a reduced risk for incident Alzheimer’s disease and related dementia in patients with pulmonary hypertension, according to a study published in Brain Communications.